Article info
Review
Autoantibody testing in idiopathic inflammatory myopathies
- Correspondence to Dr Anke Rietveld, Department of Neurology, Center for Neuroscience Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen 6500 HB, The Netherlands; Anke.Rietveld{at}radboudumc.nl
Citation
Autoantibody testing in idiopathic inflammatory myopathies
Publication history
- Received March 2, 2018
- Revised December 13, 2018
- Accepted January 22, 2019
- First published March 2, 2019.
Online issue publication
July 11, 2019
Article Versions
- Previous version (2 March 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies
- OptimisAtion of Diagnostic Accuracy in idioPathic inflammaTory myopathies (ADAPT study): a protocol for a prospective diagnostic accuracy study of multimodality testing in patients suspected of a treatable idiopathic inflammatory myopathy
- Machine learning algorithms reveal unique gene expression profiles in muscle biopsies from patients with different types of myositis
- The EuroMyositis registry: an international collaborative tool to facilitate myositis research
- Prevalence and clinical correlates of rheumatoid factor and anticitrullinated protein antibodies in patients with idiopathic inflammatory myopathy
- DIAGNOSIS AND TREATMENT OF INFLAMMATORY MUSCLE DISEASES
- Evaluation and treatment of inflammatory myopathies
- Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines
- A tough one to swallow
- 2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups